sb 203580 has been researched along with Carcinoma, Ductal, Breast in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X; Han, YC; Li, BL; Li, ZQ; Mi, XY; Song, M; Sun, LM; Wang, EH; Wang, R; Zhao, Y | 1 |
| Han, YC; Li, BL; Song, M; Wang, R; Zeng, XX; Zhao, Y | 1 |
2 other study(ies) available for sb 203580 and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Survival; Chi-Square Distribution; Enzyme Inhibitors; Female; Formazans; Humans; Imidazoles; Immunohistochemistry; Integrin beta3; Middle Aged; p38 Mitogen-Activated Protein Kinases; Pyridines; Retrospective Studies; Tenascin; Tetrazolium Salts; Urokinase-Type Plasminogen Activator | 2010 |
[Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Disease-Free Survival; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Female; Follow-Up Studies; Humans; Imidazoles; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Urokinase-Type Plasminogen Activator | 2007 |